Stay updated with breaking news from Increased Potency. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AUR200, a potent recombinant fusion protein, has a clinically validated MOA with a high affinity for targeting both BAFF and APRIL Upon FDA clearance of the IND, AUR 200 will be studied in a...
Researchers examined the memory B cell repertoire of individuals immunized with three doses of mRNA-based COVID-19 vaccine.
A new study describes the potential of engineered neutralizing antibodies that have a high affinity for the binding epitopes.